BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen G, Qiu H, Ke SD, Hu SM, Yu SY, Zou SQ. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling. World J Gastroenterol 2013; 19(16): 2481-2491 [PMID: 23674849 DOI: 10.3748/wjg.v19.i16.2481]
URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2481.htm
Number Citing Articles
1
Wu Liu, Eskandar Qaed, Yuelin Zhu, Wenzhang Tian, Yizhen Wang, Le Kang, Xiaodong Ma, Zeyao Tang. Research Progress and New Perspectives of Anticancer Effects of EmodinThe American Journal of Chinese Medicine 2023; 51(07): 1751 doi: 10.1142/S0192415X23500787
2
Xinyan Xue, Yunyun Quan, Lihong Gong, Xiaohong Gong, Yunxia Li. A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicologyJournal of Ethnopharmacology 2020; 261: 113121 doi: 10.1016/j.jep.2020.113121
3
Mohan Shankar G., Mundanattu Swetha, C K Keerthana, Tennyson P Rayginia, Ruby John Anto. Cancer Chemoprevention: A Strategic Approach Using PhytochemicalsFrontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.809308
4
Yue Hu, Lin Yang, Yu Lai. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanismsBiomedicine & Pharmacotherapy 2023; 162: 114585 doi: 10.1016/j.biopha.2023.114585
5
Subash Chandra Gupta, Vipin Rai. Role of Nutraceuticals in Chemoresistance to Cancer2018; : 241 doi: 10.1016/B978-0-12-812373-7.00012-7